Immunology of antiphospholipid antibodies and their interaction with plasma proteins

Lupus

Volumn 5, Issue 2, 1996, Pages 153-155

  Kandiah, D A ^a   Krilis, S A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antiphospholipid antibodies; Lupus anticoagulants; Prothrombin; 2 glycoprotein I

Indexed keywords

ACTIVATED PROTEIN C; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PLASMA PROTEIN; PROTHROMBIN;

ANTIGEN ANTIBODY REACTION; ANTIPHOSPHOLIPID SYNDROME; CHOREA; CONFERENCE PAPER; HUMAN; LIVEDO RETICULARIS; PRIORITY JOURNAL; RECURRENT ABORTION; THROMBOCYTOPENIA; THROMBOSIS; VALVULAR HEART DISEASE;

EID: 0029881159     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500212     Document Type: Conference Paper

References (31)

1. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991, 49: 193-280.
2. Kandiah DA, Krilis SA. Immunology and methods of detection of antiphospholipid antibodies. In The Antiphospholipid Syndrome. Asherson RA, Cervera R, Piette JC, Shoenfeld Y (Eds). CRC Press Boca Raton, 1996; 29-48.
3. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins : A new view of lupus anticoagulants and other 'antiphospholipid' antibodies. Blood 1994; 84: 2854-2867.
4. Triplett DA. Antiphospholipid-protein antibodies: Laboratory detection and clinical relevance. Thromb Research 1995; 78: 1-31.
5. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
6. Triplett DA, Brandt JT, Musgrave KA, Orr C. Relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988; 259: 550-554.
7. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-462
8. McNeil HP, Krilis SA, Chesterman CN. Purification of antiphospholipid antibodies using a new affinity method. Thromb Research 1988; 52: 641-648.
9. Exner T, Sahman N, Trudinger B. Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column. Biochem Biophys Res Comm 1988; 155: 1001-1007.
10. Harris EN et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-1214.
11. Harris EN et al. Cross-reactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985; 16. 1-6.
12. McNeil HP, Chesterman CN, Krilis SA. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 1989; 73: 506-513
13. 2-glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995; 89: 397-402.
14. 2-glycoprotein I antibodies derived from patients with the Antiphospholipid syndrome J Immunol 1995; 155. 1629-1636
15. 2-glycoprotein I is bound to a suitable surface. Throm Haemostasis 1995; 73: 29-34.
16. 2-glycoprotein I in the absence of phospholipid: Importance of Ag density and bivalent binding. J Immunol 1995; 154: 954-960.
17. Loeliger A. Prothrombin as cofactor in the circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh 1959; 3: 237-256.
18. Bajaj SP et al. A mechanism for the hypoprothrombinaemia of the acquired hypoprothrombinaemia-lupus anticoagulant syndrome. Blood 1983; 61: 684-692.
19. Fleck RA, Rapaport SI, Rao LV. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-519.
20. Bevers EM et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemostasis 1991; 66: 629-632.
21. Galli M et al. Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemostasis 1992; 68: 297-300.
22. 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 1995; 86: 617-623.
23. 2-glycoprotein I of the factor Xa generating activity of platelets. Thromb Haemostasis 1993; 70: 342-345.
24. 2-glycoprotein I. J Clin Pathol 1993; 46: 665-667.
25. Cariou R et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells - inhibition of thrombomodulin-dependent protein C activation. Thromb Haemostasis 1988; 60: 54-58.
26. Oosting JD et al. In vitro studies of antiphospholipid antibodies and its cofactor, beta 2-glycoprotein I, show negligible effects on endothelial cell mediated protein C activation, Thromb Haemostasis 1991; 66: 666-671.
27. Keeling DM et al. Role of beta 2-glycoprotein I and antiphospholipid antibodies in activation of protein C in vitro. J Clin Path 1993; 46: 908-911.
28. Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 1993; 81: 2618-2625.
29. Smirnov MD et al On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest 1995; 95: 309-316.
30. Bokarewa MI et al. Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene. Thromb Research 1995; 78: 193-200.
31. Arvieux J et al. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemostasis 1995; 74: 1120-1125.